Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Cyclin Dependent Kinase Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
7
14
21
28
35
42
49
56
63
70
alvocidib
(DSP-2033) / Sumitomo Pharma
riviciclib
(P27600) / Piramal Phytocare
indisulam
(E7070) / Eisai
roniciclib
(BAY1000394) / Bayer
fadraciclib
(CYC065) / Cyclacel
seliciclib
(CYC202) / Cyclacel, Cedars-Sinai
zotiraciclib
(TG02) / Cothera Biosci
RVU120
/ Ryvu Therap
milciclib
(TZLS-201) / Tiziana Life Sci
CINelim
(terameprocol) / Erimos Pharma
lunresertib
(RP-6306) / Repare Therap
AT7519
/ Novartis, Otsuka
samuraciclib
(CT7001) / Carrick Therap
AZD4573
/ AstraZeneca
enitociclib
(VIP152) / Vincerx
narazaciclib
(HX301) / Traws Pharma
tagtociclib
(PF-07104091) / Pfizer
SLS009
/ SELLAS Life Sciences
avotaciclib
(BEY1107) / BeyondBio
inixaciclib
(NUV-422) / Nuvation Bio
BPI-1178
/ Beta Pharma
GTAEXS617
/ Exscientia, GT Apeiron Therap
HS-10342
/ Jiangsu Hansoh Pharma
ebvaciclib
(PF-06873600) / Pfizer
AVZO-021
/ Avenzo Therap
BLU-222
/ Blueprint Medicines
GLR2007
/ Gan & Lee Pharma
INX-315
/ Incyclix Bio, G1 Therap
KB-0742
/ Kronos Bio
Q901
/ Qurient
SYHX1903
/ CSPC Pharma
auceliciclib
(AU3-14) / Aucentra
terameprocol topical
(EM-1421 intravaginal) / Erimos Pharma
tolfenamic acid
(NT101) / NeuroTau
